Burosumab Biosimilar (FGF23 Reference Antibody)
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
Product Specifications
Target
Burosumab Biosimilar (Anti-FGF23 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0084003 1.0 µg DNA
ANAPC10 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
K1491404 1.0 µg DNA
OR2AF1P sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details HTBM031-5PR 5 Preparations
HiPer® Random Amplification of Polymorphic DNA (RAPD) Teaching Kit
Sign In for Pricing
View Details 
MBS9016962 Inquire
Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) MRD1 Polyclonal Antibody
Sign In for Pricing
View Details